Principal Investigator


Berni Canani

Dr. Roberto Berni Canani is internationally recognized as one of the leading researchers in the area of pediatric gastroenterology, food-induced diseases and nutrition. He received his MD and PhD degrees from University of Naples “Federico II”, Naples, Italy. He is board certified in Pediatrics. 

Chief of the Pediatric Allergy Program and founder of the ImmunoNutritionLab at Ceinge Advanced Biotechnologies Research Center. He is author of more than 300 publications among scientific paper on international journals, chapters of books and reviews. His publications are widely quoted.

0 +

He is author of more than 300 publications among scientific paper on international journals, chapters of books and reviews.

4000 +

His publications are widely quoted. Of these 90 papers have been cited >100 times. H-index score 60. Total impact factor score: >2000.

0 +

Extensive local & international academic research collaborations as well as several links with industry and major companies involved in human nutrition.

He is member of many national scientific societies (Italian Society of Pediatrics, Italian Society of Pediatric Gastroenterology Hepatology and Nutrition, Italian Society of Pediatric Allergy and Immunology, Italian Society of Infectious Diseases, Italian Society of Pediatric Research). Vice-president of the Italian Society of Pediatric Gastroenterology Hepatology and Nutrition (SIGENP) (2008-2012) and chief of the food-induced diseases working group (from 2014 to 2019). He is member of the European Academy of Allergy and Clinical Immunology (EAACI) and of the European Society for Pediatric Gastroenterology Hepatology and Nutrition (ESPGHAN). He has obtained several scientific prizes for the research activity. Member of the Expert Panel (from 2011) and of the Dietetic products, Nutrition and Allergies Panel of the European Food Safety Authority (EFSA) (2012-2015). From 2013 he is enclosed in the list of Top 100 Italian Scientists of VIA-Academy.

Member of the reviewers panel of:


Dr. R.Berni Canani has developed an interdisciplinary research team and a highly integrated research clinical program to better understand the pathogenic mechanisms of GI diseases and provide the best care for children affected by these disorders. The main study aim of the program is focused on the identification of best strategies for the management of pediatric patients affected by food allergies and food intolerances, and for the identification of innovative strategies to induce immune tolerance in children affected by food allergy. A bench to bedside approach is used to investigate pathophysiological basis of pediatric food-induced diseases including animal models, peripheral blood cells culture from children, epigenetics biomarkers involved in IgE- and in non-IgE-mediated food allergy, gut microbiota structure and function analysis. His studies on gut microbiome, oral tolerance and immunonutrition have already been translated into novel concepts and lead to a paradigm shift in the pathogenesis and treatment of food allergy and of other pediatric diseases.